Science & Enterprise logo
Science for business people. Enterprise for scientists.
  • Advaxis, Karolinska Institutet to Collaborate on Allergies

    Advaxis Inc., a biotechnology company in Princeton, New Jersey says it will partner with a lab at Stockholm’s Karolinska Institutet on research leading to preventions or treatments for cat allergies. Financial terms of the collaboration were not revealed. The company plans to work with the lab headed by Marianne van Hage, a professor of immunology…

  • New PhD Grad, Professor Form Building Technology Company

    An engineering professor and recent PhD graduate at University of Toronto have developed a technology to protect tall buildings from high winds and earthquakes, and started a company to take the technology to market. Civil engineering professor Constantin Christopoulos and recent Ph.D. Michael Montgomery (pictured left) developed the technology over 10 years, and founded Kinetica…

  • Presage Biosciences, Millenium to Partner on Cancer Drugs

    Presage Biosciences, a biotechnology company in Seattle, and Millenium, a division of Takeda Pharmaceuticals in Cambridge, Massachusetts, say the two companies will collaborate on the development of new cancer therapies. Financial terms of the agreement were not disclosed. Millenium develops cancer drugs, focusing on disease pathways or processes that feed cancer cells. The agreement will…

  • Database Reveals Food Ingredient Fraud Hazards

    A study drawing on a database of reports on fraud and economically motivated adulteration in food shows that olive oil, milk, honey, and saffron are among the foods found most often with adulterated ingredients. The research appears online in the April Journal of Food Science (paid subscription required) that draws on a database offered by the…

  • Simulation Software Helps Optimize Utility Transport Grids

    Software developed by Fraunhofer Institute mathematicians and engineers can simulate the workings of utility grids and thus help managers of these facilities plan and operate their critical networks. Researchers from Fraunhofer’s Institute for Algorithms and Scientific Computing in Augustin, Germany will exhibit the software at the Hannover Messe technology trade show in Germany, 23-27 April.…

  • Programmed Nanoparticles Tested as Cancer Treatments

    Researchers from four universities, three hospitals, and the biopharmaceutical company BIND Biosciences are testing a new form of cancer therapy using nanoscale particles designed to deliver a dose of targeted medicine to solid tumors. The findings, including results of early clinical trials, are published in this week’s issue of the journal Science Translational Medicine (paid…

  • Case Western Reserve Builds Utility Scale Wind Turbine

    Case Western Reserve University in Cleveland, Ohio and its industrial partners have built their largest research wind turbine, with two other turbines already erected and one in operation providing power. The new turbine resides on property owned by industrial grinder manufacturer William Sopko & Sons in nearby Euclid, the site of another university turbine. The…

  • University Licenses Research to Detect Airborne Toxins

    University of California at Riverside is licensing an engineering professor’s research on detecting airborne toxins to a local company that plans to take the technology to market. Nano Engineered Applications Inc. plans to develop the research of chemical and environmental engineer Nosang Myung (pictured right) into handheld detection devices that can spot harmful substances in…

  • Patent Issued for Technology to Suppress Stem Cell Rejection

    Athersys Inc., a biotechnology company in Cleveland, Ohio, has received a patent for its process to reduce or suppress graft-versus-host disease associated with bone-marrow stem cell transplants used to treat leukemia and related disorders. Patent 8,147,824 was issued yesterday by the U.S. Patent and Trademark Office and assigned to Athersys, as well as the Oregon…

  • U.S. Angel Investment Deals, Dollars Jump in 2011

    The number and dollar amounts of angel investment deals in the U.S. rose sharply in 2011, with financing for science-related companies comprising nearly half of those transactions. The summary report of angel investing released yesterday by the University of New Hampshire’s Center for Venture Research also shows more initial-stage involvement in start-up companies than in…